Thermo Fisher Scientific Inc. collaborates on PRECISE-SG100K proteomics study to advance biomarker discovery and improve disease understanding using population-scale protein data.
Simantini Singh Deo
Aravax appoints Carsten Hellmann and Andrew Oxtoby to its board to support PVX108 development, advancing peanut allergy immunotherapy toward Phase 3 trials.
Simantini Singh Deo
BioXcel Therapeutics, Inc. begins Phase 2a trial of BXCL501 for acute stress reactions after trauma, evaluating treatment to reduce symptoms and prevent long-term neuropsychiatric conditions.
Simantini Singh Deo
Charles River Laboratories International, Inc. partners with American Heart Association to expand heart disease awareness and prevention programs, supporting cardiovascular health initiatives.
Simantini Singh Deo